Jove
Visualize
お問い合わせ
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  3. 研究分野
  5. 生物医学と臨床科学
  7. 心血管医学と血液学
  9. 心臓病 (心血管疾患を含む)
  11. 標準的な可変リスク因子を持たない女性のc反応性タンパク質と心血管リスク: "smurfが少ないが炎症"の評価
  1. ホーム
  3. 研究分野
  5. 生物医学と臨床科学
  7. 心血管医学と血液学
  9. 心臓病 (心血管疾患を含む)
  11. 標準的な可変リスク因子を持たない女性のc反応性タンパク質と心血管リスク: "smurfが少ないが炎症"の評価

関連する実験動画

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.1K

標準的な可変リスク因子を持たない女性のC反応性タンパク質と心血管リスク: "SMuRFが少ないが炎症"の評価

Paul M Ridker1, Gemma A Figtree2, M Vinayaga Moorthy1

  • 1Center for Cardiovascular Disease Prevention, Divisions of Preventive Medicine and Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, 900 Commonwealth Avenue, Boston, MA 02215, USA.

European heart journal
|August 29, 2025

PubMed で要約を見る

まとめ
この要約は機械生成です。

高感度C反応性タンパク質 (hsCRP) は,従来の危険因子を持たない女性の心血管疾患のリスクを特定します. hsCRP濃度の上昇は30年以上にわたる重大な心血管疾患を予測し,予防心血管学におけるその有用性を強調しています.

科学分野:

  • 心血管疾患の疫学
  • 予防的な心臓科
  • バイオマーカーの発見

背景:

  • 伝統的な心血管リスク因子介入 (高血圧,脂質不全,糖尿病,喫煙) は,特に女性では多くのイベントを逃します.
  • 女性の心臓血管疾患は 十分に検出されず 十分に治療されていません
  • 高感度C反応性タンパク質 (hsCRP) のような炎症バイオマーカーの役割は,標準の可変リスク因子 (SMuRFs) を欠いている女性のリスクの特定において不明である.

研究 の 目的:

  • 伝統的な危険因子を持たない女性の心血管リスクの検出におけるhsCRPの有用性を評価する.
  • 初期に健康な女性を対象に,hsCRPの基準値と長期の重大心血管疾患リスクとの関連を評価する.

主な方法:

  • 女性の健康研究から最初は健康だったアメリカ人女性12,530人を30年間追跡した分析.
  • 出発時のhsCRP濃度が測定され,参加者はMACE (心筋梗塞,再血管化,不全性脳卒中,心血管性死亡) についてモニタリングされた.
  • ハザード比 (HRs) と累積的発生率曲線は,hsCRPクインティールと臨床的値で,リグレッションモデルを用いて計算された.

主要な成果:

  • 30年間で合計973件のMACEが発生しました.
  • 心血管疾患を経験した女性は,hsCRPの中央値が著しく高かった (2. 22 vs 1. 50 mg/ L).
キーワード:
動脈硬化症C反応性タンパク質炎症リスク要因女性

さらに関連する動画

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.7K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.3K

関連する実験動画

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.1K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.7K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.3K

関連する概念動画

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

213
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

77
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
77
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

119
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
119
Relative Risk01:12

Relative Risk

340
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
340
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー
  • hsCRPの上昇は,他の要因を調整した後でも,冠動脈疾患 (CHD),不全性脳卒中,および全身心血管疾患のリスクの増加と関連していました.

    • 結論:

    • 心血管疾患は,伝統的な危険因子を持たないが,hsCRPが上昇した女性 ("SMuRFが少ないが炎症") で頻繁に発生する.
    • hsCRPは,女性における未発見の心臓血管リスクの特定に役立つバイオマーカーです.
    • これらの発見は"SMuRFが少ないが炎症のある"個体に対するスタチン療法などの標的型介入を支持する.